methamphetamine has been researched along with win 51708 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angulo, JA; Cadet, JL; Yu, J | 1 |
| Angulo, JA; Cadet, JL; Wang, J; Yu, J | 1 |
| Angulo, JA; Angulo, N; Yu, J | 1 |
| Ali, SF; Angulo, JA; Wang, J; Xu, W | 1 |
| Ali, SF; Angulo, JA; Wang, J; Xu, W; Zhu, J | 1 |
| Angulo, JA; Ghazaryan, N; Mexhitaj, I; Ordonez, D; Tulloch, I | 1 |
6 other study(ies) available for methamphetamine and win 51708
| Article | Year |
|---|---|
Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.
Topics: Androstanes; Animals; Autoradiography; Benzimidazoles; Binding Sites; Brain; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fever; Glial Fibrillary Acidic Protein; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Piperidines; Signal Transduction; Substance P; Tyrosine 3-Monooxygenase | 2002 |
Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Topics: Androstanes; Animals; Benzimidazoles; Brain; Cell Count; Corpus Striatum; Drug Interactions; Fluoresceins; Fluorescent Dyes; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Methamphetamine; Mice; Nerve Degeneration; Neurokinin-1 Receptor Antagonists; Neurotoxicity Syndromes; Organic Chemicals; Receptors, Neurokinin-1; Tyrosine 3-Monooxygenase | 2004 |
Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
Topics: Androstanes; Animals; Benzazepines; Benzimidazoles; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Presynaptic Terminals; Receptors, Dopamine D1; Receptors, Neurokinin-1 | 2004 |
Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure.
Topics: Androstanes; Animals; Benzimidazoles; Corpus Striatum; Dopamine Agents; Endocytosis; Endosomes; Enzyme Activation; In Situ Nick-End Labeling; Male; Methamphetamine; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Receptors, Neurokinin-1 | 2008 |
The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice.
Topics: Analysis of Variance; Androstanes; Animals; Apoptosis; Benzimidazoles; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Dose-Response Relationship, Drug; Drug Combinations; Electrochemistry; Immunotoxins; In Situ Nick-End Labeling; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Nitric Oxide; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Substance P; Tyrosine | 2009 |
Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.
Topics: Analysis of Variance; Androstanes; Animals; Benzazepines; Benzimidazoles; Bromodeoxyuridine; Cell Proliferation; Central Nervous System Stimulants; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Drug Administration Routes; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurogenesis; Neurokinin-1 Receptor Antagonists; Raclopride; Receptors, Dopamine; Receptors, Neurokinin-1 | 2011 |